475
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia

, , , &
Pages 2468-2472 | Received 20 Mar 2017, Accepted 17 Jun 2017, Published online: 09 Jul 2017

References

  • Evans K, Rigby AS, Hamilton P, et al. The relationships between neonatal encephalopathy and cerebral palsy: a cohort study. J Obstet Gynaecol. 2001;21:114–120.
  • Hagberg H, David Edwards AD, Groenendaal F. Perinatal brain damage: the term infant. Neurobiol Dis. 2016;92:102–112.
  • Ellis M, Manandhar N, Manandhar DS, et al. Risk factors for neonatal encephalopathy in Kathmandu, Nepal, a developing country: unmatched case-control study. BMJ. 2000;320:1229–1236.
  • Azzopardi D, Strohm B, Marlow N, et al. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med. 2014;371:140–149.
  • Hagberg H, Mallard C, Ferriero DM, et al. The role of inflammation in perinatal brain injury. Nat Rev Neurol. 2015;11:192–208.
  • Groenendaal F, de Vries LS. Fifty years of brain imaging in neonatal encephalopathy following perinatal asphyxia. Pediatr Res. 2017;81:150–155.
  • Blennow M, Hagberg H, Rosengren L. Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants? Pediatr Res. 1995;37:260–264.
  • Blennow M, Sävman K, Ilves P, et al. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta paediatr. 2001;90:1171–1175.
  • Chaparro-Huerta V, Flores-Soto ME, Merin Sigala ME, et al. Proinflammatory cytokines, enolase and S-100 as early biochemical indicators of hypoxic-ischemic encephalopathy following perinatal asphyxia in newborns. Pediatr Neonatol. 2017;58:70–76.
  • Douglas-Escobar M, Yang C, Bennett J, et al. A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res. 2010;68:531–536.
  • Garca-Alix A, Quero J. Brain-specific proteins as predictors of outcome in asphyxiated term infants. Acta paediatr. 2001;90:1103–1105.
  • Lv H, Wang Q, Wu S, et al. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clin Chim Acta. 2015;450:282–297.
  • Takahashi K, Hasegawa S, Maeba S, et al. Serum Tau protein level serves as a predictive factor for neurological prognosis in neonatal asphyxia. Brain Dev. 2014;36:670–675.
  • Thorngren-Jerneck K, Alling C, Herbst A, et al. S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res. 2004;55:406–412.
  • Ponnusamy V, Kapellou O, Yip E, et al. A study of microRNAs from dried blood spots in newborns after perinatal asphyxia: a simple and feasible biosampling method. Pediatr Res. 2016;79:799–805.
  • Looney AM, Ahearne CE, Hallberg B, et al. Downstream mRNA target analysis in neonatal hypoxic-ischaemic encephalopathy identifies novel marker of severe injury: a proof of concept paper. Mol Neurobiol. 2016[Dec 12];[1–9]. [Epub ahead of print]. doi: 10.1007/s12035-016-0330-4
  • Perlman M, Shah PS. Hypoxic-ischemic encephalopathy: challenges in outcome and prediction. J Pediatr. 2011;158:e51–e54.
  • Fiala M, Baumert M, Surmiak P, et al. Umbilical markers of perinatal hypoxia. Ginekol Pol. 2016;87:200–204.
  • Ahearne CE, Boylan GB, Murray DM. Short and long term prognosis in perinatal asphyxia: an update. World J Clin Pediatr. 2016;5:67–74.
  • Murray DM, O’Connor CM, Ryan CA, et al. Early EEG Grade and outcome at 5 years after mild neonatal hypoxic ischemic encephalopathy. Pediatrics. 2016;138:4.
  • Stuart A, Otterblad Olausson P, Källen K. Apgar scores at 5 minutes after birth in relation to school performance at 16 years of age. Obstet Gynecol. 2011;118:201–208.
  • Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016;12:563–574.
  • Rohrer JD, Woollacott IO, Dick KM, et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology. 2016;87:1329–1336.
  • Mattsson N, Zetterberg H, Janelidze S, et al. Plasma tau in Alzheimer disease. Neurology. 2016;87:1827–1835.
  • Matsushige T, Ichiyama T, Kajimoto M, et al. Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis. J Neurol Sci. 2009;280:59–61.
  • Blennow K, Brody DL, Kochanek PM, et al. Traumatic brain injuries. Nat Rev Dis Prim. 2016;2:16084.
  • Olsson B, Lautner R, Andreasson U, et al. CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15:673–684.
  • Saman S, Kim W, Raya M, et al. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem. 2012;287:3842–3849.
  • Shahim P, Darin N, Andreasson U, et al. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study. Pediatr Neurol. 2013;49:31–39.
  • Shahim P, Gren M, Liman V, et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep. 2016;6:36791.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.